BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.

Autoria(s): Harkin, Paul; Carser, Judith; Quinn-O'Brien, Jennifer; Michie, C.O.; O'Brien, E; McCluggage, W.G.; Maxwell, Perry; Lamers-Schmidt, Elisabeth; Loie, TF; Williams, AR; Kennedy, Richard
Data(s)

01/12/2011
Identificador

http://pure.qub.ac.uk/portal/en/publications/brca1-is-both-a-prognostic-and-predictive-biomarker-of-response-to-chemotherapy-in-sporadic-epithelial-ovarian-cancer(abca0264-dd95-45e2-bfbb-82c1c3331aee).html

http://dx.doi.org/10.1016/j.ygyno.2011.08.017
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Harkin , P , Carser , J , Quinn-O'Brien , J , Michie , C O , O'Brien , E , McCluggage , W G , Maxwell , P , Lamers-Schmidt , E , Loie , T F , Williams , A R & Kennedy , R 2011 , ' BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer. ' Gynecologic Oncology , vol 123(3) , no. 3 , pp. 492-498 . DOI: 10.1016/j.ygyno.2011.08.017
Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2729 #Obstetrics and Gynaecology #/dk/atira/pure/subjectarea/asjc/2700/2730 #Oncology
Tipo

article
Acesso ao item digital